冬病夏治敷贴疗法联合清肺定喘汤治疗哮喘-慢性阻塞性肺疾病重叠综合征

目的探讨冬病夏治敷贴疗法联合清肺定喘汤治疗哮喘-慢性阻塞性肺疾病重叠综合征(ACOS)的治疗效果。方法选取ACOS患者128例,按照随机数表法分为对照组与观察组,各64例,对照组给予常规西医治疗,观察组在对照组的基础上联合冬病夏治敷贴疗法联合清肺定喘汤治疗。对比2组临床疗效、免疫功能、肺功能、炎症因子,主要临床症状、体征评分。结果观察组治疗后的临床总有效率(90.63%,58/64)高于对照组(73.44%,47/64)(P<0.05)。治疗后,2组第1秒用力呼气容积(FEV_1)、用力肺活量(FVC)、最大呼气流量(PEF)升高,且观察组高于对照组(P<0.05);2组CD8^(+)降低,且观察组低于对照组(P<0.05);2组CD3^(+)、CD4^(+)/CD8^(+)、CD4^(+)升高,且观察组高于对照组(P<0.05);2组白介素-10(IL-10)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)降低,且观察组低于对照组(P<0.05);2组喘息、咳嗽、咳痰、湿啰音或哮鸣音评分均降低,且观察组低于对照组(P<0.05)。结论冬病夏治敷贴疗法联合清肺定喘汤治疗可有效改善哮喘-慢性阻塞性肺疾病重叠综合征患者的临床症状,可降低机体炎症因子水平、提高免疫水平,改善肺功能。

冬病夏治敷贴疗法联合孟鲁司特、噻托溴铵治疗ACOS的疗效

目的探究冬病夏治敷贴疗法联合孟鲁司特、噻托溴铵治疗哮喘-慢阻肺重叠综合征(ACOS)的疗效。方法选取2017年1—12月本院收治的86例ACOS患者为研究对象,按随机数表法分为对照组和观察组两组,每组各43例。对照组患者应用孟鲁司特、噻托溴铵治疗,观察组患者在对照组基础上实施冬病夏治敷贴疗法。比较2年后两组患者疗效,比较治疗前、治疗2年后两组患者中医症候积分、病情控制程度[哮喘控制测试评分(ACT)、慢性阻塞性肺疾病患者自我评估测试(CAT)]、肺功能[第1 s用力呼气容积(FEV1)、肺活量(FVC)、FEV1/FVC]。结果治疗2年后,观察组患者总体疗效高于对照组,差异有统计学意义(P<0.05),但两组总有效率比较,差异有统计学意义(P>0.05);两组中医症候积分均较治疗前下降,且观察组中医症候积分低于对照组,差异有统计学意义(P<0.05);两组ACT评分较治疗前上升,且观察组ACT评分高于对照组,差异均有统计学意义(P<0.05);两组CAT评分均较治疗前降低,且观察组CAT评分低于对照组,差异均有统计学意义(P<0.05);两组FEV1、FVC、FEV1/FVC均较治疗前上升,且观察组各指标均高于对照组,差异均有统计学意义(P<0.05)。结论冬病夏治敷贴疗法联合孟鲁司特、噻托溴铵治疗ACOS有助于改善总体疗效,能有效减轻患者症状,控制患者病情,并有利于改善肺功能。

个性化护理联合冬病夏治敷贴治疗小儿支气管哮喘的临床体会

目的:探讨个性化护理联合冬病夏治敷贴治疗小儿支气管哮喘的临床效果。方法:选取本院2015年7月至2017年8月所收治的160例小儿支气管哮喘患者,将其随机分为研究组和对照组,每组患儿80例,研究组采取冬病夏治敷贴+个性化护理治疗,对照组采取冬病夏治敷贴+常规护理治疗,对比两组临床效果。结果:治疗后研究组肺功能指标明显优于对照组(P<0.05);研究组日间及夜间哮喘症状评分、均明显优于对照组(P<0.05);研究组负性情绪及依从率均明显优于对照组(P<0.05)。结论:个性化护理联合冬病夏治敷贴治疗小儿支气管哮喘的临床效果显著,可有效改善患儿病情,改善患儿的负面情绪,提高治疗依从性,临床可将积极推广此种治疗方案。

冬病夏治穴位敷贴及拔罐治疗小儿咳嗽变异性哮喘临床疗效观察

目的:观察冬病夏治穴位敷贴及拔罐对治疗小儿咳嗽变异性哮喘的临床疗效。方法:选择2009年7月~2012年8月丰南区中医院收治的咳嗽变异性哮喘患儿207例,将其随机分为治疗组105例,对照组102例,对照组采用酮替芬、布地奈德喷雾剂治疗,治疗组在对照组基础上联合运用冬病夏治穴位敷贴及拔罐疗法,以3年为1个疗程,比较两组患儿临床疗效、每年感冒次数、每年激素用量以及不良反应。结果:治疗组患儿治疗总有效率为93.33%,对照组患儿治疗总有效率为96.08%,两组治疗总有效率比较,差异不具有统计学意义(P>0.05);治疗组每年感冒次数、每年激素用量、不良反应发生率以及每年因本病住院人次均显著低于对照组,差异具有统计学意义(P<0.05)。结论:冬病夏治穴位敷贴及拔罐联合西医常规药物治疗,能够有效降低患儿每年的激素用量、药物不良反应发生率以及患儿的再住院率,从而有助于降低医疗成本,值得临床推广运用。

Efficacy comparison of different forms of dog-days acupoint application for prevention and treatment of chronic bronchitis

Objective: To analyze the clinical effect of traditionaldog-days acupoint application and Magic Acupuncture Patch (Manji) in the prevention and treatment of chronic bronchitis (CB) in remission stage in the past five years, and explore the principle of action and effective stimulation, to provide the evidence for treating CB by acupoint application. Methods: A retrospective study was conducted on 405 patients with CB who met the inclusion criteria. All patients were treated with dog-days acupoint application or Magic Acupuncture Patch between 2013 and 2017. The clinical data of 405 patients were statistically analyzed to compare the prevention and treatment effects of dog-days acupoint application and Magic Acupuncture Patch, and different degrees of stimulation of dog-days acupoint application. Results: Among the dog-days acupoint application groups, the total effective rate was 63.6% in the light stimulation group, 93.1% in the moderate stimulation group, and 94.8% in the strong stimulation group. The differences in the total effective rate between the light stimulation group and the moderate stimulation group, as well as the strong stimulation group, were statistically significant (both P<0.05). There was no significant difference in the total effective rate between the moderate stimulation group and the strong stimulation group (P>0.05). The total effective rate was 83.9% in the dog-days acupoint application group, versus 45.4% in the Magic Acupuncture Patch group, and there was a statistically significant difference between the two groups (P<0.05). Conclusion: The efficacy of dog-days acupoint application in the prevention and treatment of CB is better than that of Magic Acupuncture Patch;the degree of stimulation is the basis for the effect of dog-days acupoint application on prevention and treatment of CB, and the moderate and strong stimulations are more appropriate.